Skip to main content

Table 4 Univariate analysis with clinicopathologic and 18F-FDG PET/MRI parameters

From: Prognostic value of simultaneous 18F-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer

Parameters Hazards ratio (95% CI) P value Corrected P value†
T stage (3/4a vs. 1/2) 2.61 (1.12–6.05) 0.026* 0.286
Lymphatic invasion (yes vs. no) 3.40 (1.47–7.85) 0.004* 0.044*
Venous invasion (yes vs. no) 3.21 (1.26–8.22) 0.015* 0.165
Perineural invasion (yes vs. no) 3.34 (1.44–7.76) 0.004* 0.044*
SUVmax (> 5.14 vs. ≤ 5.14) 2.13 (0.96–3.03) 0.055 0.605
MTV (> 11.08 vs. ≤ 11.08) 3.48 (1.50–8.05) 0.004* 0.044*
TLG (> 59.33 vs. ≤ 59.33) 2.86 (1.23–6.63) 0.014* 0.154
ADCmean (< 1054.0 vs. ≥ 1054.0) 2.02 (1.15–4.68) 0.024* 0.264
(SUVmax/ADCmean) × 1000 (> 13.9 vs. ≤ 13.9) 2.43 (1.04–5.71) 0.041* 0.451
(MTV/ADCmean) × 1000 (> 10.8 vs. ≤ 10.8) 3.82 (1.63–8.94) 0.002* 0.022*
(TLG/ADCmean) × 1000 (> 108.9 vs. ≤ 108.9) 3.76 (1.52–9.25) 0.004* 0.044*
  1. *Statistically significant (P < 0.05). †Multiple comparison correction by Bonferroni